CRISPR loss‐of‐function screen identified INSIG2 as a candidate for the vulnerability in hepatitis B virus‐integrated liver cancer cells.
All Keywords
【저자키워드】 HBV, CRISPR/Cas, Liver cancer, CDK2, pooled library screen,
【저자키워드】 HBV, CRISPR/Cas, Liver cancer, CDK2, pooled library screen,